Market News

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

The president has told Bank of America and JPMorgan Chase to stop cutting conservatives off from doing business.

The story of home affordability in the U.S. told from a single front porch.

Recent court cases reveal how middlemen are facilitating a booming trade, eluding a crackdown.

The real costs of owning a house in neighborhoods that are vulnerable to flooding and wildfires are becoming clearer.

Analogies for artificial intelligence abound. In recent years, analysts have likened the development of AI to the advent of electricity, the Industrial Revolution, contact with extraterrestrials, and at least fifty other things. One analogy, however, appears to have won out over the rest: AI is like

ECB amends monetary policy implementation guidelines as part of regular review

As Hollywood's financing structures diversify, private capital is increasingly funding the big screen and changing the types of movies that are being made.

David Robinson, formerly leading OpenAI’s safety transparency efforts, wrote in The Atlantic that ChatGPT maker “has thrived by trial and error”

Key deals this week: Onsemi, Mattel, Nebius, Advanced Micro Devices, and more